Biogen (BIIB) Non-Current Assets (2009 - 2026)

Biogen's Non-Current Assets history runs 18 years deep, the most recent figure standing at $20.3 billion for Q1 2026.

• In Q1 2026, Non-Current Assets fell 0.56% year-over-year to $20.3 billion; the TTM figure through Mar 2026 stood at $81.4 billion (down 0.96% YoY), while the FY2025 annual figure was $20.5 billion, down 0.62% from the prior year.
• Non-Current Assets was $20.3 billion for Q1 2026 at Biogen, down from $20.5 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $21.5 billion in Q3 2024 to a low of $14.7 billion in Q2 2023.
• Historically, Non-Current Assets has averaged $18.4 billion across 5 years, with a median of $19.8 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Non-Current Assets retreated 11.26% in 2022, then jumped 35.38% in 2023.
• A 5-year view of Non-Current Assets shows it stood at $14.8 billion in 2022, then surged by 35.38% to $20.0 billion in 2023, then increased by 3.04% to $20.6 billion in 2024, then dropped by 0.62% to $20.5 billion in 2025, then dropped by 0.84% to $20.3 billion in 2026.
• The last three Non-Current Assets figures came in at $20.3 billion (Q1 2026), $20.5 billion (Q4 2025), and $20.3 billion (Q3 2025), per Business Quant data.